📝 TruAlt Bioenergy Limited — results explained
Quarter ended June 2026 (Q1 FY27)
TruAlt Bioenergy Limited reported revenue of ₹627 crore for the quarter ended June 2026 (Q1 FY27), up 106.2% from ₹304 crore in the same quarter last year, and up 5.3% sequentially over the March 2026 quarter.
Net profit rose 1085.4% year-on-year to ₹59 crore, from ₹5 crore. Earnings per share (EPS) came in at ₹6.67.
Operating profit stood at ₹133 crore — an operating margin (OPM) of 21.2%, compared with 13.8% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, TruAlt Bioenergy Limited posted revenue of ₹1,728 crore, with a net profit of ₹97 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹2,051 crore with a net profit of ₹151 crore.
Valuation snapshot
At the current price of ₹441.35, TRUALT has a market capitalisation of ₹3,785 crore and a trailing P/E of about 25.0.
Within the Other Agricultural Products industry, it is the 2nd-largest of the 59 companies we track by market value.
Shareholding pattern
As of Sep 2026, promoters held 71.38%, foreign institutional investors (FIIs) 0.63%, domestic institutional investors (DIIs) 9.09%, public shareholders 18.91% of TruAlt Bioenergy Limited.